Cited by 234Cytokine Signaling Pathways and InteractionsPsoriasis: Treatment and PathogenesisNF-κB Signaling Pathways

The STAT3 isoforms α and β have unique and specific functions

Maritano, Diego, Sugrue, Michelle L, Tininini, Silvia, Dewilde, Sarah, Strobl, Birgit, Fu, XinPing, Murray-Tait, Victoria, Chiarle, Roberto +1 more·2004·Nature Immunology

Abstract

Signal transducer and activator of transcription 3 (STAT3) is the main mediator of interleukin 6 (IL-6)-type cytokine signaling. It exists in two isoforms: the full-length STAT3 alpha and the truncated STAT3 beta, generally thought to act as a dominant negative factor. To assess their relative functions, we ablated the expression of either isoform by gene targeting. We show here that in vivo STAT3 beta is not a dominant negative factor. Its expression can rescue the embryonic lethality of a STAT3-null mutation and it can by itself induce the expression of specific STAT3 target genes. Nevertheless, STAT3 alpha has nonredundant roles such as modulation of cellular responses to IL-6 and mediation of IL-10 function in macrophages.

Integrity signals

Registry

Crossref · 10.1038/ni1052

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Maritano, D., Sugrue, M. L., Tininini, S., Dewilde, S., Strobl, B., Fu, X., Murray-Tait, V., Chiarle, R., & Poli, V.
Affiliations
  • University of Dundee (GB)
  • Beth Israel Deaconess Medical Center (US)
  • University of Turin (IT)
  • Cancer Research UK (GB)
Corresponding author
Poli, Valeria
Venue
Nature Immunology
Published
2004-03-14
Volume
5
Issue
4
Pages
401-409
ISSN
  • 1529-2908 (ISSN-L)
  • 1529-2916
OpenAlex
W1601667381
Cited by
234
References
5
Citations by year
2026: 5 · 2025: 14 · 2024: 9 · 2023: 9 · 2022: 10 · 2021: 10 · 2020: 10 · 2019: 11 · 2018: 15 · 2017: 8 · 2016: 7 · 2015: 7 · 2014: 15 · 2013: 8 · 2012: 12
FWCI
5.44
Type
journal article
Language
en
Open access
closed
Locations
  • Nature Immunology (publishedVersion)
  • PubMed (publishedVersion)
  • Discovery Research Portal (University of Dundee) (submittedVersion)
  • Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
Keywords
STAT3, isoform-specific function, dominant negative effect, IL-6 signaling, IL-10, macrophages, embryonic lethality, gene targeting, cytokine signaling
MeSH terms
Animals, DNA-Binding Proteins, Fertility, Genes, Lethal, Inflammation, Kidney, Liver, Lung, Mutation, Immunoblotting, Trans-Activators, Interleukin-6, Protein Isoforms, STAT3 Transcription Factor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review